TERUMO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,627 JPY | +0.90% |
|
-1.35% | +13.67% |
| Apr. 12 | Penumbra, Inc. : The underdog in healthcare |  |
| Mar. 18 | Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation | CI |
Presenter SpeechNaoki Muto (Executives)Hello. I am the CFO, Muto. I will give an overview of o...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
2024-05-13
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,627
JPY
Average target price
2,976
JPY
Spread / Average Target
+13.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.67% | 25.02B | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +3.43% | 26.53B | |
| -0.32% | 24.96B | |
| +5.22% | 22.86B |
- Stock Market
- Equities
- 4543 Stock
- News Terumo Corporation
- Transcript : Terumo Corporation, Q3 2023 Earnings Call, Feb 09, 2023